{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T20:34:19Z","timestamp":1794170059016,"version":"4.8.0"},"reference-count":45,"publisher":"Tech Science Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["oncol res"],"published-print":{"date-parts":[[2018,3,5]]},"abstract":"<jats:p>Carbonic anhydrase (CA) IX has emerged as a promising target for cancer therapy. It is highly upregulated in hypoxic regions and mediates pH regulation critical for tumor cell survival as well as extracellular acidification of the tumor microenvironment, which promotes tumor aggressiveness\n via various mechanisms, such as augmenting metastatic potential. Therefore, the aim of this study was to analyze the complex interdependency between CA IX and the tumor microenvironment in prostate tumor cells with regard to potential therapeutic implications. CA IX was upregulated by hypoxia\n as well as acidosis in prostate cancer cells. This induction did not modulate intracellular pH but led to extracellular acidification. Pharmacological inhibition of CA IX activity by U104 (SLC-0111) resulted in a reduction in tumor cell growth and an increase in apoptotic cell death. Intracellular\n pH was reduced under normoxic and even more so under hypoxic conditions when CA IX level was high. However, although intracellular pH regulation was disturbed, targeting CA IX in combination with daunorubicin or cisplatin did not intensify apoptotic tumor cell death. Hence, targeting CA IX\n in prostate cancer cells can lead to intracellular pH dysregulation and, consequently, can reduce cellular growth and elevate apoptotic cell death. Attenuation of extracellular acidification by blocking CA IX might additionally impede tumor progression and metastasis. However, no beneficial effect was seen when targeting CA IX in combination with chemotherapeutic drugs.<\/jats:p>","DOI":"10.3727\/096504017x14965111926391","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T11:05:18Z","timestamp":1497956718000},"page":"191-200","source":"Crossref","is-referenced-by-count":24,"title":["Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity"],"prefix":"10.32604","volume":"26","author":[{"given":"Anne","family":"Riemann","sequence":"first","affiliation":[{"name":"Julius-Bernstein-Institut f\u00fcr Physiologie, Universit\u00e4t Halle-Wittenberg, Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"G\u00fcttler","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Strahlentherapie, Universit\u00e4t Halle-Wittenberg, Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Haupt","sequence":"additional","affiliation":[{"name":"Julius-Bernstein-Institut f\u00fcr Physiologie, Universit\u00e4t Halle-Wittenberg, Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Wichmann","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Strahlentherapie, Universit\u00e4t Halle-Wittenberg, Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Reime","sequence":"additional","affiliation":[{"name":"Julius-Bernstein-Institut f\u00fcr Physiologie, Universit\u00e4t Halle-Wittenberg, Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bache","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Strahlentherapie, Universit\u00e4t Halle-Wittenberg, Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Vordermark","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Strahlentherapie, Universit\u00e4t Halle-Wittenberg, Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Thews","sequence":"additional","affiliation":[{"name":"Julius-Bernstein-Institut f\u00fcr Physiologie, Universit\u00e4t Halle-Wittenberg, Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","reference":[{"issue":"8","key":"b1","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/bies.20606","article-title":"The evolving concept of tumor microenvironments","volume":"29","year":"2007","journal-title":"BioEssays"},{"issue":"23","key":"b2","first-page":"6449","article-title":"Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review","volume":"49","year":"1989","journal-title":"Cancer Res."},{"issue":"7092","key":"b3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature04871","article-title":"Hypoxia signalling in cancer and approaches to enforce tumour regression","volume":"441","year":"2006","journal-title":"Nature"},{"issue":"5","key":"b4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.biotechadv.2016.04.005","article-title":"Hypoxic tumor microenvironment: Opportunities to develop targeted therapies","volume":"34","year":"2016","journal-title":"Biotechnol Adv."},{"issue":"1","key":"b5","first-page":"76","article-title":"Cycling hypoxia: A key feature of the tumor microenvironment","volume":"1866","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"b6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1582-4934.2009.00994.x","article-title":"Tumour hypoxia induces a metabolic shift causing acidosis: A common feature in cancer","volume":"14","year":"2010","journal-title":"J Cell Mol Med."},{"issue":"11","key":"b7","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/ijc.23818","article-title":"Acidosis induces multi-drug resistance in rat prostate cancer cells (AT1) in vitro and in vivo by increasing the activity of the p-glycoprotein via activation of p38","volume":"123","year":"2008","journal-title":"Int J Cancer"},{"issue":"11","key":"b8","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1007\/s00424-014-1458-6","article-title":"Acidic priming enhances metastatic potential of cancer cells","volume":"466","year":"2014","journal-title":"Pflugers Arch."},{"issue":"5","key":"b9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00424-009-0677-8","article-title":"Protons make tumor cells move like clockwork","volume":"458","year":"2009","journal-title":"Pflugers Arch."},{"issue":"2","key":"b10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1593\/neo.05697","article-title":"Impact of extracellular acidity on the activity of P-glycoprotein and the cytotoxicity of chemotherapeutic drugs","volume":"8","year":"2006","journal-title":"Neoplasia"},{"issue":"4","key":"b11","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10555-014-9531-3","article-title":"Microenvironmental acidosis in carcinogenesis and metastases: New strategies in prevention and therapy","volume":"33","year":"2014","journal-title":"Cancer Metast Rev."},{"issue":"10","key":"b12","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.bbamem.2014.10.015","article-title":"Proton channels and exchangers in cancer","volume":"1848","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"b13","first-page":"400","article-title":"Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors","volume":"4","year":"2014","journal-title":"Front Physiol."},{"issue":"15","key":"b14","first-page":"4011","article-title":"Metabolic consequences of a reversed pH gradient in rat tumors","volume":"54","year":"1994","journal-title":"Cancer Res."},{"issue":"24","key":"b15","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1158\/0008-5472.CAN-11-2520","article-title":"Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors","volume":"71","year":"2011","journal-title":"Cancer Res."},{"issue":"2","key":"b16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10555-007-9064-0","article-title":"Regulation of tumor pH and the role of carbonic anhydrase 9","volume":"26","year":"2007","journal-title":"Cancer Metast Rev."},{"issue":"17","key":"b17","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1158\/0008-5472.CAN-03-2224","article-title":"Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion","volume":"64","year":"2004","journal-title":"Cancer Res."},{"issue":"Pt 7","key":"b18","first-page":"1077","article-title":"Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion","volume":"124","year":"2011","journal-title":"J Cell Sci."},{"issue":"2","key":"b19","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0014-4827(03)00351-3","article-title":"Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin","volume":"290","year":"2003","journal-title":"Exp Cell Res."},{"issue":"44","key":"b20","first-page":"5210","article-title":"Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche","volume":"32","year":"201","journal-title":"Oncogene"},{"issue":"2","key":"b21","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.3390\/molecules20022323","article-title":"Targeting carbonic anhydrase IX activity and expression","volume":"20","year":"2015","journal-title":"Molecules"},{"issue":"9","key":"b22","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.18632\/oncotarget.2882","article-title":"Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells","volume":"6","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"b23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02388128","article-title":"Use of the pH-sensitive dye BCECF to study pH regulation in cultured human kidney proximal tubule cells","volume":"13","year":"1991","journal-title":"J Tissue Cult Methods"},{"issue":"5","key":"b24","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1083\/jcb.105.5.2145","article-title":"Fura-2 measurement of cytosolic free Ca2+ in monolayers and suspensions of various types of animal cells","volume":"105","year":"1987","journal-title":"J Cell Biol."},{"issue":"6","key":"b25","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","article-title":"A new generation of Ca2+ indicators with greatly improved fluorescence properties","volume":"260","year":"1985","journal-title":"J Biol Chem."},{"issue":"11","key":"b26","doi-asserted-by":"crossref","first-page":"19777","DOI":"10.3390\/ijms151119777","article-title":"Betulinic acid derivatives NVX-207 and B10 for treatment of glioblastoma\u2014An in vitro study of cytotoxicity and radiosensitization","volume":"15","year":"2014","journal-title":"Int J Mol Sci."},{"issue":"4","key":"b27","first-page":"1025","article-title":"Extracellular acidosis elevates carbonic anhydrase IX in human glioblastoma cells via transcriptional modulation that does not depend on hypoxia","volume":"29","year":"2006","journal-title":"Int J Oncol."},{"issue":"3","key":"b28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bmcl.2004.11.057","article-title":"Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates","volume":"15","year":"2005","journal-title":"Bioorg Med Chem Lett."},{"issue":"1","key":"b29","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","year":"2009","journal-title":"Cancer Res."},{"issue":"9","key":"b30","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: Suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","year":"2011","journal-title":"Cancer Res."},{"issue":"1","key":"b31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ab.2008.06.033","article-title":"Direct determination of intracellular daunorubicin in intact confluent monolayers of AT1 prostate carcinoma cells using a multiwell-multilabel counter","volume":"381","year":"2008","journal-title":"Anal Biochem."},{"key":"b32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1152\/physiol.00035.2006","article-title":"Intracellular pH sensors: Design principles and functional significance","volume":"22","year":"2007","journal-title":"Physiology"},{"issue":"7","key":"b33","doi-asserted-by":"crossref","first-page":"e22445","DOI":"10.1371\/journal.pone.0022445","article-title":"Acidic environment leads to ROS-induced MAPK signaling in cancer cells","volume":"6","year":"2011","journal-title":"PLoS One"},{"key":"b34","first-page":"69","article-title":"Prognostic significance of carbonic anhydrase IX expression in cancer patients: A meta-analysis","volume":"6","year":"2016","journal-title":"Front Oncol."},{"issue":"3","key":"b35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/pros.2990090306","article-title":"Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers","volume":"9","year":"1986","journal-title":"Prostate"},{"key":"b36","first-page":"27","article-title":"Overcoming hypoxia-mediated tumor progression: Combinatorial approaches targeting pH regulation, angiogenesis and immune dysfunction","volume":"4","year":"2016","journal-title":"Front Cell Dev Biol."},{"issue":"6","key":"b37","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1517\/17460441.2015.1038235","article-title":"Designing carbonic anhydrase inhibitors for the treatment of breast cancer","volume":"10","year":"2015","journal-title":"Expert Opin Drug Discov."},{"issue":"13","key":"b38","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1158\/0008-5472.CAN-15-1862","article-title":"Disrupting hypoxia-induced bicarbonate transport acidifies tumor cells and suppresses tumor growth","volume":"76","year":"2016","journal-title":"Cancer Res."},{"issue":"26","key":"b39","doi-asserted-by":"crossref","first-page":"42857","DOI":"10.18632\/oncotarget.17143","article-title":"Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells","volume":"8","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"b40","first-page":"75","article-title":"Analysis of the impact of extracellular acidity on the expression and activity of P-glycoprotein and on the P-glycoprotein-mediated cytotoxicity of daunorubicin in cancer cell by microfluidic chip technology","volume":"37","year":"2015","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"8","key":"b41","doi-asserted-by":"crossref","first-page":"e0161040","DOI":"10.1371\/journal.pone.0161040","article-title":"The sulfamate small molecule CAIX inhibitor S4 modulates doxorubicin efficacy","volume":"11","year":"2016","journal-title":"PLoS One"},{"key":"b42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejpb.2016.09.018","article-title":"Inhibition of carbonic anhydrase IX in glioblastoma multiforme","volume":"109","year":"2016","journal-title":"Eur J Pharm Biopharm."},{"issue":"21","key":"b43","doi-asserted-by":"crossref","first-page":"8512","DOI":"10.1021\/jm4009532","article-title":"Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides\/sulfamides\/sulfamates","volume":"56","year":"2013","journal-title":"J Med Chem."},{"issue":"5","key":"b44","first-page":"335","article-title":"Differential in vitro inhibitory effects of anticancer drugs on tumor-associated carbonic anhydrase isozymes CA IX and CA XII","volume":"30","year":"2008","journal-title":"Methods Find Exp Clin Pharmacol."},{"issue":"52","key":"b45","doi-asserted-by":"crossref","first-page":"85861","DOI":"10.18632\/oncotarget.13040","article-title":"P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors","volume":"7","year":"2016","journal-title":"Oncotarget"}],"container-title":["Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.techscience.com\/uploads\/attached\/file\/20240524\/20240524092418_11936.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T21:35:34Z","timestamp":1733520934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v26n2\/56630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3,5]]}},"alternative-id":["0965-0407(20180305)26:2L.191;1-"],"URL":"https:\/\/doi.org\/10.3727\/096504017x14965111926391","relation":{},"ISSN":["0965-0407"],"issn-type":[{"value":"0965-0407","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3,5]]}}}